BMY : Analysis & Opinions

  1. These 5 Drug Patents Will Expire in 2017

    January 16, 2017
    Investopedia looks at the top drug patents about to expire in 2017
  2. Bristol-Myers Trades Ex-Dividend Wednesday

    January 4, 2017
    Bristol-Myers will send its dividend payment on Feb. 1 to shareholders of record as of Jan. 6.
  3. Bristol-Myers Declares 39-Cent Cash Dividend

    December 9, 2016
    The new dividend is payable Feb. 1, 2017, to shareholders of record as of Jan. 6, 2017.
  4. Assessing Bristol-Myers Stock Valuation (BMY)

    December 5, 2016
    Shares of Bristol-Myers Squibb have risen almost 11% in the past 30 days. But has investors' optimism run too far?
  5. Many Billion-Dollar ‘Biobuck’ Drug Deals Go Bust

    November 28, 2016
    Despite the high-value deal announcements, a high percentage of biotech deals fail to meet milestones.
  6. Bristol-Myers Hodgkin Lymphoma Drug OKed in EU (BMY)

    November 23, 2016
    Opdivo continues its success spree, securing approval from European Commission for Hodgkin lymphoma.
  7. Bristol-Myers Opdivo Drug Does Well in Study (BMY)

    November 14, 2016
    Bristol-Myers Squibb’s Opdivo drug helped patients with advanced stomach cancer live longer in a new study.
  8. Bristol-Myers Opdivo Nips at Keytruda's Heels (BMY)

    November 14, 2016
    The approval brings Bristol-Myers in line with rival Merck's Keytruda drug for head-and-neck cancer.
  9. Inside the Vanguard Health Care ETF: Bristol-Myers (BMY, VHT)

    November 14, 2016
    Coming at No. 9 on the weighting list, Bristol-Myers Squibb is one of several health care giants within the Vanguard Health ...
  10. Bristol-Myers Sinks $100M in NASH, Fibrosis (BMY)

    November 14, 2016
    Bristol-Myers will pay $100 million to Japanese drug firm Nitto to develop a liver fibrosis drug.
  11. AVEO Collaborates With Bristol-Myers Squibb for RCC Drug (AVEO, ...

    September 22, 2016
    AVEO initiates clinical trial with a unique combination of drugs for treating advanced stage RCC.
  12. MRK: How Merck's Stock Price Rose 31.42% in 6 Months

    September 3, 2016
    After sinking 6.99% during calendar year 2015, Merck's stock price soared 31.42% during the six-month period between Feb. ...
  13. Top 5 Health Care Stocks of 2016 (AMGN, BMY)

    August 25, 2016
    Discover why the baby boomers are benefiting the health care sector. Explore five health care stocks that are well positioned ...
  14. 8 Stocks for Active Traders (VRX,FCX,F,BAC,SIRI)

    August 10, 2016
    These eight stocks have the potential to deliver significant returns in a short period of time.
  15. Bristol-Myers Stock Falls Despite Q2 Beat (BMY)

    July 29, 2016
    Fears about declining sales in the company's cancer treatment, Yervoy, were seemingly too much to overcome.
  16. Bristol-Myers Trades Ex-Dividend Wednesday (BMY)

    June 29, 2016
    Bristol-Myers will send its dividend payment on August 22 to shareholders of record as of July 1.
  17. Gilead Stock: Analyzing 5 Key Suppliers (GILD)

    April 29, 2016
    Take a closer look at several key pharmaceutical companies providing Gilead Sciences with important inputs to its pharmaceutical ...
  18. Bristol-Myers Squibb Buys Into Hot Pharma Segment

    April 4, 2016
    Bristol-Myers Squibb (NYSE: BMY) is readying itself for a fresh acquisition. The pharmaceutical giant announced last month ...
  19. 3 Best Dividend-Paying U.S. Health Care Mutual Funds (VGHCX, ...

    April 2, 2016
    Find out which mutual funds are paying the highest dividend yields in the health care sector, which has underperformed all ...
  20. Portfolio Trends in 2016 (VGHCX)

    March 25, 2016
    Evaluate the composition of the Vanguard Health Care Fund, and study how the fund's makeup has evolved over the previous ...
  21. Bristol-Myers' Earnings Forecasts a Healthy Dose of Growth

    January 26, 2016
    You'd be hard-pressed to find a hotter health care stock with Bristol Myers' drug pipeline combined with its consistent execution. ...
  22. The World's Top 10 Biotechnology Companies (JNJ, ROG.VX)

    December 22, 2015
    Learn how the marriage of science and technology is changing the world of medicine and creating some of the largest multinational ...
  23. Pfizer Stock Is Like An Extended Release Drug

    August 12, 2015
    Pfizer is a leading research-driven pharmaceutical company, but how good is its financial health?
  24. Buy These Stocks on The Pullback (LEN, FNF)

    June 24, 2015
    These four stocks are in upward sloping trend channels and have recently pulled back toward the bottom of the channel, providing ...
  25. Spotlight on Peregrine's Bavituximab Expansion (PPHM, BMY)

    June 3, 2015
    Shareholders of clinical-stage biopharmaceutical company Peregrine Pharmaceuticals (NASDAQ: PPHM) haven't fared well over ...
  26. Who are Gilead Sciences' (GILD) main competitors?

    May 22, 2015
    Learn about the pharmaceutical company Gilead Sciences and its main competitors. Explore the company's role in creating HIV-preventing ...
  27. Who are Pfizer's (PFE) main competitors?

    May 20, 2015
    Learn about Pfizer's place in the pharmaceutical industry, and find out which major drug manufacturers are among its main ...
  28. A Quick Guide To Healthcare ETFs

    May 8, 2015
    The healthcare industry offers a broad variety of sector ETFs but it’s difficult to avoid exposure to pharmaceuticals and ...
  29. How Bristol-Myers Squibb Makes the World Healthier

    April 10, 2015
    Innovation and acquisition: an in depth look at pharma giant Bristol-Myers Squibb.
  30. Effective Risk Control With Scaling Trading Strategies

    April 2, 2015
    Scaling strategies allow for greater risk control than simple entries or exits, letting traders seek the most advantageous ...
  31. Why These Could Be 2015's 10-Best Pharma Stocks (ABBV, ALXN)

    March 17, 2015
    The pharmaceutical stocks covered here have significant potential going forward. Here's why.
  32. How A Strong Greenback Affects the Economy

    March 2, 2015
    The fact that the strong dollar has an effect on the US economy is indisputable, but is the overall impact positive or negative? ...
  33. Interested In Pharmaceutical Stocks? Try Novartis (ADR)

    February 26, 2015
    Novartis AG, is the world's leading pharmaceutical company by sales. Here is a closer look at Novartis, and how its financials ...
  34. Is It A Breakout? See The Point-And-Figure Chart

    November 18, 2014
    These stocks have broken out of a triple top formation using point-and-figure charting, a bullish sign.
  35. These Astute Bets Helped Hedge Funds Win Big

    May 13, 2014
    Some astute bets helped hedge fund managers increase their average take by 50% in 2013, though the majority of funds were ...
  36. It's No Accident That Drugs Are Expensive

    August 30, 2013
    Branded drugs are expensive in large part because it's expensive and risky to develop them
  37. Will Immunotherapy Disrupt The Oncology Market?

    August 20, 2013
    Immunotherapy could radically change the treatment of cancer, and the revenue opportunities for pharmaceutical companies.
  38. 8 Stages Of New Drug Development

    July 29, 2013
    Understanding biotech data isn't easy. What is a clinical trial, what are the various phases, and why do the results of these ...
  39. After A Good Run, Novartis Looks Fairly Valued

    June 12, 2013
    Novartis is a well-balanced, high-quality pharma with growth credentials, but also a fair valuation today.
  40. The “Healthy” Play In Contract Research Organizations

    April 17, 2013
    The pharmaceutical industry is under pressure to do more with less. That means it will be farming out many of is mundane ...
  41. Abbott Labs Spins Off AbbVie: Which Is The Better Buy?

    January 4, 2013
    January 2 was the first day of trading for the pharmaceutical spin-off.
  42. 4 Stocks Hitting Highs During The Pullback

    May 6, 2011
    Four stocks that are holding up well during a short-term market pullback.
  43. Novo Nordisk Still One Of The Best Around

    May 3, 2011
    Novo Nordisk is one of the best pharmaceutical companies in the world - and it's priced accordingly.
  44. Roll With Your Spinoff

    August 17, 2010
    If you own a stock that's contemplating a spinoff, consider the possibility that the new entity rather than the parent is ...
  45. The Best IPOs Of 2009

    December 16, 2009
    Chinese companies stole the show in the initial public offering market in 2009, making some lucky (or smart) investors very ...
  46. The 5 Most Important Drugs In America

    July 28, 2009
    A look at the top-selling drugs finds that a few that make more of a difference to the company's bottom line than others. ...